Application of combined omics platforms to accelerate biomedical discovery in diabesity. - Wikidata - awgldk - TriplyDB

Application of combined omics platforms to accelerate biomedical discovery in diabesity.

Application of combined omics platforms to accelerate biomedical discovery in diabesity.

http://www.wikidata.org/entity/Q37005069

about

Integrative analysis of longitudinal metabolomics data from a personal multi-omics profile MicroRNA-205 targets tight junction-related proteins during urothelial cellular differentiation.Model organism proteomics as a tool for the study of host-microbiome interactions.Metabolomics in the developmental origins of obesity and its cardiometabolic consequences.Biomarkers of insulin sensitivity and insulin resistance: Past, present and future.Integrative Metabolic Signatures for Hepatic Radiation Injury.The promise of metabolic phenotyping in gastroenterology and hepatology.Isotopic Ratio Outlier Analysis of the S. cerevisiae Metabolome Using Accurate Mass Gas Chromatography/Time-of-Flight Mass Spectrometry: A New Method for Discovery.Lower Preprandial Insulin and Altered Fuel Use in HIV/Antiretroviral-Exposed Infants in Cameroon.Metabolomic insights into the intricate gut microbial-host interaction in the development of obesity and type 2 diabetes.Advanced mass spectrometry-based multi-omics technologies for exploring the pathogenesis of hepatocellular carcinoma.Metabotyping and its application in targeted nutrition: an overview.Relieving the cardiometabolic disease burden: a perspective on phytometabolite functional and chemical annotation for diabetes management.Enhanced Isotopic Ratio Outlier Analysis (IROA) Peak Detection and Identification with Ultra-High Resolution GC-Orbitrap/MS: Potential Application for Investigation of Model Organism Metabolomes.

P2860

Q30832988-E592BB9F-B9CB-4CD8-AC83-6A9C1C3CE680 Q34157668-D6759767-536D-40B7-9BAA-54766E113212 Q35109893-FDBBF3F1-22F7-4BE9-92F9-D2B5498FD82B Q35525760-C15527FB-FB6E-414B-9AED-DF3F1DF53327 Q35652813-E95B6C03-DF8F-43CB-9240-EA82ED1E6AF8 Q35654209-D36562B5-0403-4116-A909-CC3CBFD28AB8 Q35701279-1F2DBE54-826E-4B81-8C51-FE562EAB249D Q35906943-9B8F28B3-23DE-4A49-B05E-6C52115469A6 Q36060489-3B5FD9B5-426F-4EA3-A13B-E3A6ABB842DF Q36208733-E221125E-C54B-421B-998F-60387B86356C Q38217062-AD453D9F-D040-4BF9-8803-89F712115D69 Q38655730-D4EEE39C-9430-413E-BE7E-FDF56FE4C29B Q44222588-102C856C-939D-47DB-83B2-E1C07B8B7171 Q48218569-093C8B58-BF87-420A-A4C2-A08B78103EBC

P2860

Application of combined omics platforms to accelerate biomedical discovery in diabesity.

http://www.wikidata.org/entity/Q37005069

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Application of combined omics platforms to accelerate biomedical discovery in diabesity.

@en

Application of combined omics platforms to accelerate biomedical discovery in diabesity.

@nl

type

label

Application of combined omics platforms to accelerate biomedical discovery in diabesity.

@en

Application of combined omics platforms to accelerate biomedical discovery in diabesity.

@nl

prefLabel

Application of combined omics platforms to accelerate biomedical discovery in diabesity.

@en

Application of combined omics platforms to accelerate biomedical discovery in diabesity.

@nl

P1433

Q37005069-4943E4EF-DE81-494C-8A37-BB9D602B8980

P1476

Q37005069-5A11927A-546A-47E4-8470-EB936CEE5639

P2093

Q37005069-00CF8BBF-C584-44E0-96DA-AFC6840E0EEC

Q37005069-31027562-EA7F-470D-941C-4F051C04CB18

Q37005069-83B0EEDB-AD91-4F97-96D8-95F30C1819EE

Q37005069-9143E218-7932-4010-A2F4-E801B40CE7C0

Q37005069-980F4E36-DD79-427D-9A3C-ABF0FFCBEF04

Q37005069-9C589B15-8ECB-41A4-8B2B-D44286BF7F70

Q37005069-A7B17F85-F332-42A0-9997-826B9B370D82

Q37005069-B579DE3C-896A-45E8-ABD7-C7C2BCD18451

Q37005069-C72138A5-F794-4F27-B9B1-4D7BB14EE576

Q37005069-D7928CA3-798C-433C-BD96-8D7725E442C5

P2860

Q37005069-008FCDE7-5E02-4716-8580-8177932FDC2C

Q37005069-0537E660-0619-49F2-99DA-CC609F235452

Q37005069-05F64423-8D80-45CD-A30C-A8AB2381D393

Q37005069-082E502F-C6B4-4C23-8467-9D9AB6375A2B

Q37005069-0BC835D0-3B79-4EB9-8DCB-A0F6BD2C29F1

Q37005069-18DAB2E2-F010-4AB2-A8E8-A5631741E431

Q37005069-1D82E8FD-9516-45BF-816E-979847A7B705

Q37005069-250CB0A7-FD31-495A-954E-EA64FEF98665

Q37005069-31D0228D-A907-41EC-86D9-D181E6C1E9AB

Q37005069-35F08532-8076-445F-9EB7-F1F7E8C1EB75

P304

Q37005069-CEA33592-6689-48D8-B140-E3DFADA2118E

P31

Q37005069-7702AABF-D178-4F55-AE8F-CA3A27A1AEF6

P356

Q37005069-32670D68-091F-42F5-BBAF-F78A27191DD3

P407

Q37005069-941C8CDE-0C53-4619-A765-BF1EA0ACC131

P478

Q37005069-978DE661-2EF5-4D5E-8B36-E3CD78D397EE

P50

Q37005069-0DE7CDD4-310C-46B5-82C5-1F62F6BF7F52

P577

Q37005069-0C434395-A75D-42B6-8C5B-532AF69C3F7A

P5875

Q37005069-2DB28B8F-6ED9-4DAF-A9B2-43A9CDD06806

P698

Q37005069-9D1FD2B2-B5FA-4A2C-878A-5235100CD616

P932

Q37005069-34BE1EB2-098E-47DE-A806-1BF45AECD497

P356

P1433

Annals of the New York Academy of Sciences

P1476

Application of combined omics platforms to accelerate biomedical discovery in diabesity.

@en

P2093

Barbara B Kahn

http://www.w3.org/2001/XMLSchema#string

Charles Burant

http://www.w3.org/2001/XMLSchema#string

Christopher B Newgard

http://www.w3.org/2001/XMLSchema#string

Gabriele V Ronnett

http://www.w3.org/2001/XMLSchema#string

Irwin J Kurland

http://www.w3.org/2001/XMLSchema#string

Joe Shambaugh

http://www.w3.org/2001/XMLSchema#string

John A Ryals

http://www.w3.org/2001/XMLSchema#string

John Shockcor

http://www.w3.org/2001/XMLSchema#string

Mark Sanders

http://www.w3.org/2001/XMLSchema#string

Steven M Fischer

http://www.w3.org/2001/XMLSchema#string

P2860

Potential etiologic and functional implications of genome-wide association loci for human diseases and traits

Organization of GC/MS and LC/MS metabolomics data into chemical libraries

FiehnLib: Mass Spectral and Retention Index Libraries for Metabolomics Based on Quadrupole and Time-of-Flight Gas Chromatography/Mass Spectrometry

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance

C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase

FoxO1 target Gpr17 activates AgRP neurons to regulate food intake

The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha

Advances in structure elucidation of small molecules using mass spectrometry

The Effect of LC-MS Data Preprocessing Methods on the Selection of Plasma Biomarkers in Fed vs. Fasted Rats.

Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling.

P304

1-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/NYAS.12116

http://www.w3.org/2001/XMLSchema#string

P407

P478

1287

http://www.w3.org/2001/XMLSchema#string

P50

Domenico Accili

P577

2013-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236673834

http://www.w3.org/2001/XMLSchema#string

P698

23659636

http://www.w3.org/2001/XMLSchema#string

P932

3709136

http://www.w3.org/2001/XMLSchema#string